The Journal of Steroid Biochemistry and Molecular Biology 2001: Vol 79 Index

5 Pages·2001·0.85 MB·English

The Journal of
Steroid Biochemistry
&
Molecular Biology
PERGAMON Journal of Steroid Biochemistry & Molecular Biology 79 (2001) VI-VII
www.elsevier.com/locate/jsbmb
Subject Index
Aromatase Brain
alternations in hepatic expression of fatty-acid metabolising characterization and purification of a protein binding to the
enzymes in, deficient (ArKO) mice and their reversal by cis-acting element for, -specific exon | of the mouse aro-
treatment with 17f-estradiol or a peroxisome proliferator, | | matase gene, 255
analysis of transcriptional regulation of human breast, 151 cytochrome P450 aromatase (CYP/9) in, of non-human
and COX-2 expression in human breast cancers, 41 primate, 247
bone phenotype of the, deficient mouse, 49 phosphorylation processes mediate rapid changes of aromatase
comparative approach to structure-function studies of mamma- activity in, 261
lian, 289 Breast cancer
deficient (ARKO) mice accumulate excess adipose tissue, 3 adaptive hypersensitivity to estradiol: potential mechanism for
expression in male germ cells, 203 secondary hormonal responses in, patients, 115
identification of the regulatory regions of the human, P450 a novel estrogen receptor downregulator: Faslodex (ICI
(CYP/9) gene involved in placenta-specific expression, 173 182,780) and its future possibilities in, 209
in atherosclerotic lesions of human aorta, 67 aromatase and COX-2 expression in human, 41
local endocrine effects of aromatase inhibitors within, 93 Breast tissue
modulation of expression in human breast tissue, 35 analysis of transcriptional regulation of human, aromatase,
molecular pharmacology of, and its regulation by endogenous 151
and exogenous agents, 75 local endocrine effects of aromatase inhibitors within, 93
ovarian phenotype of the, knockout mouse (ArKO), 181 modulation of aromatase expression in human, 35
overexpression transgenic mice model, 27 peptide inhibition of cytokine-stimulated aromatase activity in,
peptide inhibition of cytokine-stimulated, activity in breast fibroblasts, 165
tissue fibroblasts, 165 potential role of estrogen in aromatase regulation in, 157
phosphorylation processes mediate rapid changes of brain,
activity, 26] Cytochrome P450 aromatase
potential role of estrogen in, regulation in the breast, 157 differential tissue distribution, developmental programming,
regulation of, activity in bone-derived cells: possible role of estrogen regulation and promoter characteristics of, genes
mitogen-activated protein kinase, 61 in teleost fish, 305
regulation of, by nuclear receptors, 187 expression of the, encoding gene in cattle and sheep, 279
role of, in endometrial disease, 19 in the non-human primate brain, 247
tissue-specific expression of the human CYP/9, gene in ovary phylogeny, expression, and enzyme activity of Zebrafish, genes,
and adipose tissue of transgenic mice, 193 299
Aromatase gene
characterization and purification of a protein binding to the cis- Endometrial disease
acting element for brain-specific exon | of the, in mouse, 255 role of aromatase in, 19
Aromatase inhibitors Endometrium
adjuvant trials of, determining the future landscape of adjuvant EM-652 (SCH57068) a pure SERM having complete antiestro-
endocrine therapy, 133 genic activity in the, 213
biological and clinical effects of, in neoadjuvant therapy, 103 Estradiol
chemoprevention with, trial strategies, 143 adaptive hypersensitivity to, and potential mechanism for
comparative clinical pharmacology and pharmacokinetic inter- secondary hormonal responses in breast cancer patients,
actions of, 85 115
local endocrine effects of, within the breast, 93 alternations in hepatic expression of fatty-acid metabolising
17x%-methyl testosterone is a competitive, in JAR choriocarci- enzymes in ArKO mice and their reversal by treatment with
noma cells and macrophage-like TH! cells in culture, 239 17B-, 11
second-line randomized studies of, 109 Estrogen(s)
stepwise, suppression manipulating the estrostat, 127
Bone
phenotype of the aromatase deficient mouse, 49 Faslodex (ICI 182,780)
regulation of aromatase activity in , -derived cells: possible role a novel estrogen receptor downregulator: future possibilities in
of mitogen- activated protein kinase, 61 breast cancer, 209
PII: S0960-0760(01)00166-2
Subject Index
Fatty-acid metabolising enzymes Neoadjuvant therapy
alternations in hepatic expression of, in ArKO mice and their biological and clinical effects of aromatase inhibitors in, 103
reversal by treatment with 17{-estradiol or a peroxisome Nuclear receptor(s)
proliferator, 11 Regulation of aromatase by, 187
Germ cells Placenta
aromatase expression in male, 203 identification of the regulatory regions of the human aromatase
P450 (CYP/9) gene involved in, -specific expression, 173
Protein kinase
Human aorta
regulation of aromatase activity in bone-derived cells: possible
aromatase in atherosclerotic lesions of, 67
role of mitogen-activated, 61
Letrozole
SERM (selective estrogen receptor modulators)
aromatase Overexpression transgenic mice model: cell type
EM-652 (SCH57068) a pure, having complete antiestrogenic
specific expression and use of, to abrogate mammary hyper-
activity in the mammary gland and endometrium, 213
plasia without affecting normal physiology, 27
where do, and aromatase inhibitors now fit into breast cancer
treatment algorithms? 227
17x%-Methyl testosterone
is a competitive inhibitor of aromatase activity in JAR chor- Transgenic mice
iocarcinoma cells and macrophage-like TH] cells in culture, tissue-specific expression of the human CYP/9 aromatase gene
239 in ovary and adipose tissue of, 193
The Journal of
Steroid Biochemistry
&
Molecular Biology
PERGAMON Journal of Steroid Biochemistry & Molecular Biology 79 (2001) VIII-IX
www.elsevier.com/locate/jsbmb
Author Index
Akira S., 11 Fiirbass R., 279 Masamura S., 115
Anderson E., 227 Mason R.P., 49
Anderson T.J., 103 Galeraud-Denis I., 203 Matsumoto T., 151, 255
Antich P.P., 49 Genissel C., 203 McPherson R., 115
Ghilchik M.W., 165 Mendelson C.R., 173, 193
Giguere V., 213 Miller W.R., 93, 103
Baillien M., 261
Ball G.F., 261 Goss P.E., 143 Misso M.L., 3
Balthazart J., 261 Goto K., 187 Mor G., 239
Bélanger A., 213 Graham S., 289 Mu Y.-M., 187
Benahmed M., 203 Greger D., 289 Murakami H., 67
Berstein L.M., 157 Gurates B., 19 Murakami K., 61
Bhat A.S., 75
Bilinska B., 203 Hamilton C.J., 157 Naftolin F., 239
Blankenstein M.A., 41 Harada N., 67, 151, 255 Nanu L., 49
Blijham G.H., 41 Hewitt K.N., 3 Nawata H., 187
Boeddinghaus I.M., 85 Hinshelwood M.M., 193 Nishi Y., 187
Bourguiba S., 203 Hirasawa G., 49 Nomura M., 187
Britt K.L., 3, 181 Honda S.-i., 151 Nortier J.W.R., 41
Brodie A.M.H., 41 Honda S.-I., 255
Brueggemeier R.W., 75 Howell A., 227 Okabe T., 187
Bulun S.E., 19 Howell S.J., 227 Okada T., 11
Buzdar A.U., 109 Hsiao P.-H., 299
Okubo T., 35
Onishi S., 11
Inoue M., 61
Callard G.V., 305 Oz O.K., 3, 49
Itoh T., 35
Cameron D.A., 103
Carreau S., 203
Parish D., 165
Jeng M.-H., 115
Chen S., 35, 239
Parkey R.W., 49
Jones M.E.E., 3, 181
Chen T., 41
Proietto J., 3
Joomprabutra S., 75
Chiang E.F.-1., 299
Purohit A., 165
Chung B.-c., 299
Kalbe C., 279
Clark G.M., 157
Ragaz J., 133
Kamat A., 173
Clarke R., 227
Reed M.J., 165
Kao Y.-C., 35
Conley A., 289
Kinoshita Y., 35 Resko J.A., 247
Constantinescu A., 49
Kirma N., 27 Richards J.A., 75
Corbin C.J., 289
Kishida M., 305 Robertson J.F.R., 209
Robertson K.M., 3
DeJong P.C., 41
Labrie C., 213 Rosankiewicz J., 165
Demers L.M., 157
Labrie F., 213 Roselli C.E., 247
Dixon J.M., 93, 103
Lambard S., 203
Dowsett M., 85
Lawson J., 49 Saibara T., 11
Drummond A.E., 181
Leury B.J., 3 Said H.M., 279
Dyson M., 181
Levallet J., 203 Sakamoto H., 151
Loénning P.E., 127 Santen R., 115
Elbers J.R.J., 41 Long B.J., 41 Santen R.J., 157
Eliza M., 239 Lu Q., 41 Santner S., 115
Sasano H., 67
Fang Z., 19 Macpherson N., 41 Schipper M.E.I., 41
Findlay J.K., 181 Mandava U., 27 Schwerin M., 279
Fulton A., 41 Mapes S., 289 Sebastian S., 19
PII: S0960-0760(01)00193-5
Author Index
Segawa T., 61 Tekmal R.R., 27 Wiita B., 239
Shim W.-S., 115 Thijssen J.H., 41 Wood E., 305
Shizuta Y., 11 Thorburn A.W., 3 Wreford N.G., 3, 181
Shozu M., 61 Toda K., 11
Simard J., 213 Tong S.-K., 299 Yanase T., 187
Simpson E.R., 3, 49, 181 Trant J., 289 Yang C., 35
Singh A., 165 Tremblay A., 213 Yang H.-J., 61
Slee P.H.T.J., 41 Tremblay G., 213 Yang S., 19
Song J., 239 Tsyganov E., 49 Yao S., 3
Song R., 115 Yoshimura N., 151
Strasser K., 143 van de Ven J., 41 Yu B., 35
Sumitani H., 61 van Gorp J.M.H.H., 41 Yue W., 115, 157
Vanselow J., 279
Takayanagi R., 187 Zerwekh J.E., 49
Takeda K., 11 Walters K., 289 Zhou D., 35
Tamura M., 19 Wang J.-P., 115, 157 Zhou J., 19
Tchoudakova A.V., 305 Whetstone J.L., 75 Zsolnai A., 279